CentraState Medical Center has begun offering patients the latest UroLift® 2 System that uses the Prostatic Urethral Lift procedure for patients with Benign Prostatic Hyperplasia (BPH), a non-cancerous condition that can negatively impact a man’s quality of life.
Surgeon Troy Sukkarieh, MD, recently performed the first Urolift procedure using the new Urolift device in a Monmouth County hospital setting. The procedure is ideal for those with BPH who experience the urgent need to urinate, difficulty starting a urine stream, increased frequency of urination and other symptoms.
“The technology allows us to perform the procedure in just a few minutes, so the total time spent at the hospital is two-four hours rather than days,” says Dr. Sukkarieh. “There is very little recovery time because most men don’t need a catheter, and patients have been very pleased with the results and lack of side effects.”
BPH is a common condition in which the prostate enlarges as men age, affecting nearly 40 million Americans and 500 million men worldwide. Most men living with BPH symptoms take prescription medications after they’re diagnosed, although these may not provide adequate relief and can cause dizziness, fatigue, and sexual dysfunction.
The UroLift® 2 System treatment offers a mechanical method that yields rapid, lasting relief from BPH, which results from an enlarged prostate that narrows or blocks the urethra. During the outpatient procedure, a device is placed through the obstructed urethra to access the prostate, allowing the surgeon to insert tiny implants on either side of the prostate to hold open the obstructed pathway that blocks urine flow.
“Left untreated, those with BPH may be at risk for permanent bladder damage, urinary tract infections or other problems that develop over time” added Dr. Sukkarieh.
The UroLift System is covered nationally by Medicare and by most major private insurance payors.